Prognostic Markers in Head and Neck Cancer Patients Treated with Nivolumab

To investigate whether peripheral blood biomarkers predict the outcome of anti-PD-1 antibody treatment for head and neck squamous cell carcinoma (HNSCC). Patients treated with nivolumab for platinum-refractory recurrent or metastatic HNSCC were retrospectively reviewed. Fifty-three patients treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishikawa, Daisuke, Suzuki, Hidenori, Koide, Yusuke, Beppu, Shintaro, Kadowaki, Shigenori, Sone, Michihiko, Hanai, Nobuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316608/
https://www.ncbi.nlm.nih.gov/pubmed/30477171
http://dx.doi.org/10.3390/cancers10120466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316608/
https://www.ncbi.nlm.nih.gov/pubmed/30477171
http://dx.doi.org/10.3390/cancers10120466

Ejemplares similares